News
Pasithea has announced the commencement of a Phase I/Ib open-label trial of PAS-004 for treating adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback